Background The prognostic efficacy of quantitative platelet activity in atrial fibrillation (AF)
remains unclear. Objective The purpose of this study was to evaluate the platelet count …

Background Information regarding the significance of platelet (PLT) count on outcome of
atrial fibrillation (AF) patients who are treated with anticoagulants is limited. Methods We …

Whether thrombocytopenia substantively increases the risk of hemorrhage associated with
anticoagulation in patients with atrial fibrillation (AF) is not established. The purpose of this …

Background The mean platelet volume to platelet count ratio (MPV/PC) has been
investigated in the diagnosis, prognosis and risk stratification in several diseases. However …

Early detection of atrial fibrillation patients at high risk for stroke is important. There are some
studies which indicate that mean platelet volume (MPV) determines the prognosis and risk in …

Platelet size, measured as mean platelet volume (MPV), is associated with platelet reactivity.
MPV has been identified as an independent risk factor for future stroke and myocardial …

Atrial fibrillation is the most common sustained arrhythmia in clinical practice. It is important
to specify patients with a high risk of thromboembolus due to elevated procoagulant and …

Background CHADS2 (congestive heart failure, hypertension, age≥ 75 years, diabetes
mellitus, stroke) and CHA2DS2‐VASc (congestive heart failure, hypertension, age≥ 75 …

Background Thrombocytopenia is associated with increased mortality in the general
population, but few data exist in patients with atrial fibrillation (AF) taking oral anticoagulants …

Background This systematic review with meta-analysis aimed to determine the strength of
evidence for evaluating the association of platelet cellular and functional characteristics …